The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AMYRIS INC COM NEW 03236M200   464,913 292,398 SH   SOLE   292,398 0 0
ATRECA INC CL A COM 04965G109   964,878 1,206,097 SH   SOLE   1,206,097 0 0
BIONTECH SE SPONSORED ADS 09075V102   22,333,808 148,674 SH   SOLE   148,674 0 0
BUTTERFLY NETWORK INC CL A COM 124155102   2,487,067 1,011,003 SH   SOLE   1,011,003 0 0
CUREVAC N V COM N2451R105   9,804,436 1,625,943 SH   SOLE   1,625,943 0 0
EXSCIENTIA ADS 30223G102   8,479,545 1,590,909 SH   SOLE   1,590,909 0 0
IMMUNCORE HLDGS PLC ADS 45258D105   32,924,996 576,923 SH   SOLE   576,923 0 0
LUMIRADX LTD SHS G5709L109   12,857,143 14,285,714 SH   SOLE   14,285,714 0 0
VIR BIOTECHNOLOGY INC COM 92764N102   39,461,884 1,559,142 SH   SOLE   1,559,142 0 0